PMR Response Assessment — SCE Rheumatology MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: D — If there is no significant improvement (>70%) within 1 week of starting appropriate-dose Prednisolone the diagnosis of PMR should be reconsidered
A hallmark of PMR is the dramatic and rapid response to moderate-dose glucocorticoids (12.5-25 mg Prednisolone). BSR 2010 PMR guidelines and ACR/EULAR 2012 PMR criteria include treatment response as a supportive feature. If there is no significant improvement (>70%) within 1 week alternative diagnoses should be actively considered: late-onset RA malignancy (particularly myeloma lymphoma solid tumours) infection inflammatory myopathy hypothyroidism and GCA. Failure to respond should trigger re-evaluation with appropriate investigations rather than simply increasing the steroid dose.
Reference: BSR 2010 PMR guidelines; Dasgupta B et al 2012 ACR/EULAR PMR criteria